Cover |
12 Months Ended |
|---|---|
Mar. 31, 2023 | |
| Cover [Abstract] | |
| Document Type | POS AM |
| Amendment Flag | true |
| Amendment Description | The registrant is filing this post-effective amendment to update the financial statements and other information contained in the registrants’ registration statement on Form S-1 (Registration No. 333-270511) (the “Registration Statement”), which was declared effective by the Securities and Exchange Commission on May 12, 2023. The Registration Statement relates to the sale of up to 4,796,206 shares of common stock, $0.001 par value per share, by two selling stockholders identified in the prospectus. As of August 3, 2023, no shares of common stock have been sold pursuant to the Registration Statement. No additional securities are being registered pursuant to this post-effective amendment to the Registration Statement. All applicable registration fees were previously paid on March 14, 2023. |
| Entity Registrant Name | Nemaura Medical, Inc. |
| Entity Central Index Key | 0001602078 |
| Entity Incorporation, State or Country Code | NV |
| Entity Filer Category | Non-accelerated Filer |
| Entity Small Business | true |
| Entity Emerging Growth Company | false |